CHARACTERIZATION OF IG-MYC-BREAKPOINTS AND THEIR APPLICATION FOR QUANTITATIVE MINIMAL DISEASE MONITORING IN HIGH-RISK PEDIATRIC BURKITT-LYMPHOMA AND –LEUKEMIA. (October 2022) - Damm-Welk, C.; Möker, P.; Stadt, U.; Zimmermann, M.; Alawi, M.; Mueller, S.; Finger, J.; Knörr, F.; Riquelme, A.; Oschlies, I.; Klapper, W.; Bradtke, J.; et al.